We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Dining With Diabetes in Pennsylvania (DWD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04080960
Recruitment Status : Completed
First Posted : September 6, 2019
Last Update Posted : June 4, 2021
Information provided by (Responsible Party):
Penn State University

Brief Summary:

Penn State Extension's Dining with Diabetes program is an evidence-based community education program for people with or at risk for type 2 diabetes. The program teaches participants how to prevent or manage their disease by providing practical knowledge and strategies to make the necessary lifestyle changes that will lead to healthier living and reduction in the risk of complications. The overall goals and objectives of the program are as follows:

Increasing knowledge of healthy food choices for families with or at risk for diabetes Promoting behavior changes by offering demonstrations and tasting of healthy food.

Increasing knowledge of essential medical tests associated with diabetes management.

Promoting physical activity as a component of diabetes control. Encouraging self-management and self-efficacy skill. Connecting participants to their healthcare providers for long-term follow-up. The program is designed to meet 4 consecutive weeks and then a 3 month follow-up. Participants A1c and blood pressure are taking at the first and follow-up classes. Classes consist of a nutrition lesson, physical activity, cooking demonstration and food tasting.

Condition or disease Intervention/treatment
Diabetes Mellitus, Type 2 Behavioral: Lifestyle modification education

Layout table for study information
Study Type : Observational
Actual Enrollment : 200 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Dining With Diabetes in Pennsylvania
Actual Study Start Date : May 1, 2019
Actual Primary Completion Date : April 30, 2020
Actual Study Completion Date : April 30, 2020

Intervention Details:
  • Behavioral: Lifestyle modification education
    Lifestyle modification education and goal setting

Primary Outcome Measures :
  1. hemoglobin A1C [ Time Frame: 3 months ]
    participants can choose to have their hemoglobin A1C taken at the first and follow-up class, 3 months later

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Adults residents of Pennsylvania

Inclusion Criteria:

  • Individuals with type 2 diabetes individuals with pre-diabetes individuals at risk of developing type 2 diabetes healthy family members/caretakers healthy volunteers

Exclusion Criteria:

  • under age 18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04080960

Layout table for location information
United States, Pennsylvania
Penn State University
University Park, Pennsylvania, United States, 16802
Sponsors and Collaborators
Penn State University
Publications of Results:
Layout table for additonal information
Responsible Party: Penn State University
ClinicalTrials.gov Identifier: NCT04080960    
Other Study ID Numbers: PRAMS00036501
208113 ( Other Grant/Funding Number: NNLM )
First Posted: September 6, 2019    Key Record Dates
Last Update Posted: June 4, 2021
Last Verified: June 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 2
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases